Protecting Research That Changes Lives: Introducing MyRHC

You're developing treatments for cancer. Engineering gene therapies that could cure rare diseases. Running clinical trials that will help millions. Your research changes lives.

We make sure it stays secure.

Today, we're proud to announce the launch of MyRHC (Massachusetts Regulated, Health & Compliance) — a cybersecurity-first consulting firm built specifically for Massachusetts biotech, pharmaceutical, and life sciences research organizations.

The Problem: 59+ Compliance Frameworks and No One Speaking Your Language

Massachusetts is home to the most innovative biotech cluster in the world. From Cambridge labs pioneering CRISPR therapies to Boston pharmaceutical companies developing breakthrough treatments, our state drives global health innovation.

But here's the challenge: Massachusetts regulated industries face 59+ distinct compliance frameworks — more than almost any other state. A typical healthcare organization needs to navigate at least six overlapping frameworks simultaneously:

• 201 CMR 17.00 (Massachusetts Data Security Law — one of the nation's strictest)
• HIPAA Privacy and Security Rules (federal health data protection)
• FDA 21 CFR Part 11 (electronic records and signatures)
• NIH Guidelines (recombinant DNA research requirements)
• SOC 2 (service organization controls for vendors)
• NIST Cybersecurity Framework (federal security standards)

And that's before you add local municipal biosafety requirements, MassDEP environmental compliance, clinical trial data protection standards, or intellectual property security protocols.

The real problem isn't just the number of frameworks. It's that generic cybersecurity firms don't understand your world.

They don't know the difference between a BSL-2 and BSL-3 lab. They've never secured a clinical trial management system. They don't understand why researchers need to collaborate openly while protecting sensitive patient data. They treat compliance as a checklist, not as a strategic enabler of innovation.

We're different.

The MyRHC Approach: Cultural Intelligence Meets LTFI Automation

MyRHC isn't another cybersecurity firm trying to sell you cookie-cutter assessments. We're strategic partners who understand Massachusetts biotech culture, research workflows, and the unique regulatory landscape you navigate every day.

We Understand Your World

For biotech startups racing from Series A to first-in-human trials, we know security can't slow down your discovery timeline. We design compliance programs that move at startup speed — 6-week compliance deployment versus 17+ weeks with traditional consultants.

For academic research labs managing NIH and NSF grants, we speak your language. We understand IRB requirements, publication timelines, and the delicate balance between open scientific collaboration and data security.

For pharmaceutical companies managing FDA submissions, we know that 21 CFR Part 11 compliance isn't just about electronic signatures — it's about audit trails, data integrity, and proving your systems are trustworthy when regulators come calling.

For Contract Research Organizations (CROs) juggling multiple client requirements, we build multi-tenant security architectures that scale across different compliance frameworks without creating operational bottlenecks.

For medical device manufacturers navigating FDA cybersecurity guidance, we understand that software as a medical device (SaMD) requires a fundamentally different security approach than enterprise software.

Powered by LTFI: The Most Advanced Security Automation Platform

What makes MyRHC truly different is our partnership with LTFI (Lead the Field Intelligence) — the most innovative AI-powered security automation platform in the industry.

While other firms run manual vulnerability scans that take weeks, LTFI conducts comprehensive security assessments in hours:

• Web reconnaissance that discovers your entire attack surface across all digital properties
• Directory fuzzing that finds hidden admin panels, backup files, and exposed APIs
• Vulnerability scanning tailored to your specific technology stack
• Network discovery that maps your complete infrastructure topology
• Service enumeration identifying misconfigured systems before attackers do
• OSINT profiling revealing your organization's public exposure

But here's what matters most: LTFI doesn't just find vulnerabilities. It provides intelligent, prioritized remediation guidance tailored to your specific compliance requirements.

Need HIPAA compliance for clinical trial data? LTFI maps findings directly to HIPAA Security Rule technical safeguards.

Preparing for an FDA inspection? LTFI identifies 21 CFR Part 11 gaps in your electronic quality management system.

Securing a research database containing controlled unclassified information? LTFI validates NIST 800-171 controls required for federal grant compliance.

No Cookie-Cutter Assessments. Ever.

We start every engagement with deep discovery:

• What research are you conducting? (Cell therapy? Drug development? Medical devices?)
• What compliance frameworks apply to your specific work?
• How do researchers actually work? (Lab notebooks? Electronic data capture?)
• What systems handle your most sensitive data?
• Where are the institutional politics? (IT vs. research vs. compliance vs. legal)

Then we build a security and compliance program that enables your research, not hinders it.

The Massachusetts Compliance Landscape: Why Location Matters

Massachusetts isn't just stricter than most states — it's fundamentally different.

201 CMR 17.00: Nation-Leading Data Protection

The Massachusetts Data Security Law was one of the first comprehensive state data protection regulations in the United States. Unlike many state laws that only apply to specific industries, 201 CMR 17.00 applies to any business that handles Massachusetts resident personal information.

For life sciences companies, this means:

• Written Information Security Programs (WISP) required for all organizations
• Encryption requirements for data at rest and in transit
• Third-party vendor management with contractual security obligations
• Regular security assessments and continuous monitoring

Massachusetts HIPAA + Federal HIPAA = Stricter Requirements

While HIPAA is federal law, Massachusetts health privacy laws add additional protections:

• Massachusetts PATCH Act provides enhanced patient privacy protections
• Shield Act 2.0 protects reproductive and gender-affirming healthcare data
• Massachusetts Health Privacy Law (state-level protections beyond HIPAA)

Local Municipal Biosafety Requirements

Biotech facilities in Massachusetts must navigate varying local requirements:

• Cambridge requires registration with the Board of Health and adherence to NIH Guidelines
• Watertown mandates biotechnology facility registration and biosafety committee oversight
• Belmont has specific containment requirements for BSL-2 and BSL-3 laboratories

These aren't optional. Municipal inspectors have shut down research facilities for non-compliance.

Who We Serve: Your Research, Our Mission

MyRHC specializes in five key sectors of Massachusetts life sciences:

1. Biotech Startups (Series A-C)

Your Challenge: You're moving fast from discovery to clinical trials. Investors want to see traction. Researchers want to focus on science. But now you need HIPAA compliance for patient data, 201 CMR 17.00 compliance for your electronic lab notebooks, and SOC 2 certification to land that hospital partnership.

Our Solution: Rapid compliance deployment that gets you certified without slowing down discovery. Free HIPAA gap analysis to identify exactly what you need. Educational approach that trains your team to maintain compliance as you scale.

2. Academic Research Labs

Your Challenge: Your lab just received a major NIH grant that includes cybersecurity requirements. You're publishing cutting-edge research while protecting patient samples and genomic data. Your IT support is limited, and researchers aren't security experts.

Our Solution: Grant compliance roadmaps that satisfy NIH and NSF requirements. Security training designed for researchers, not IT professionals. Affordable programs that fit academic budgets.

3. Contract Research Organizations (CROs)

Your Challenge: You manage clinical trials for multiple pharmaceutical clients, each with different security requirements. You need SOC 2 Type II, HIPAA Business Associate Agreements, and client-specific compliance frameworks — all while maintaining efficient operations.

Our Solution: Multi-tenant security architectures that scale across clients. Automated compliance monitoring that reduces audit burden. Strategic guidance on growing your client base without expanding your compliance team.

4. Mid-Size Pharmaceutical Companies

Your Challenge: FDA inspections are coming. You need 21 CFR Part 11 compliance for your quality management systems, electronic batch records, and clinical data management platforms. Legacy systems weren't built with modern security standards in mind.

Our Solution: FDA compliance roadmaps with clear audit trails. Legacy system assessment and modernization strategies. Ongoing support for regulatory submissions and inspections.

5. Medical Device Manufacturers

Your Challenge: You're developing software as a medical device (SaMD) with embedded cybersecurity. FDA premarket guidance requires threat modeling, secure development practices, and post-market monitoring. IEC 62304 compliance adds another layer of complexity.

Our Solution: Device security assessments aligned with FDA cybersecurity guidance. Secure development lifecycle implementation. Regulatory consulting for 510(k) and PMA submissions.

The MyRHC Advantage: What Makes Us Different

1. Speed Without Compromise

6-week compliance deployment versus 17+ weeks with traditional consultants. LTFI automation handles vulnerability discovery while our experts focus on strategic guidance and remediation planning.

2. Security That Enables Innovation

We don't just say "no" to research workflows because they're "insecure." We design controls that maintain scientific collaboration while protecting sensitive data. Secure data rooms for multi-institution studies. Encrypted communication channels that don't disrupt researcher habits. Access controls that adapt to how labs actually work.

3. Educational, Not Transactional

We're not here to sell you recurring service contracts. We're here to build your internal security capabilities. Every engagement includes:

• Training for your team on maintaining compliance independently
• Documentation you can actually use (not binders that sit on shelves)
• Ongoing support when you need strategic guidance

4. Cultural Intelligence

We understand the difference between:

• Academic research culture (open collaboration, publication-driven) vs. commercial biotech (IP protection, competitive advantage)
• Early-stage startups (move fast, minimal bureaucracy) vs. established pharma (validated processes, regulatory scrutiny)
• Basic research (fundamental science) vs. clinical trials (patient safety, regulatory compliance)

This cultural understanding shapes how we design and implement security programs.

5. Massachusetts Focus

We're not trying to serve every industry in every state. We specialize in Massachusetts biotech, pharma, and life sciences. We know local regulations, attend MassBio events, understand the Cambridge innovation ecosystem, and maintain relationships with state regulatory agencies.

Our Services: Comprehensive Security and Compliance Support

LTFI Security Assessments

Comprehensive, automated security assessments covering:

• Web application security (your patient portals, research databases, collaboration platforms)
• Network infrastructure security (lab networks, data centers, cloud environments)
• OSINT analysis (what information about your organization is publicly exposed?)
• Vulnerability prioritization (what actually puts your research at risk?)

Compliance Consulting

Strategic guidance for navigating Massachusetts and federal requirements:

• HIPAA compliance programs for covered entities and business associates
• FDA 21 CFR Part 11 implementation for electronic records and signatures
• 201 CMR 17.00 written information security programs
• NIH Guidelines compliance for recombinant DNA research
• SOC 2 Type I/II readiness assessments and audit support
• NIST 800-171 for federal contractors handling controlled unclassified information

Ongoing Support and Advisory

We don't disappear after the assessment:

• Strategic cybersecurity advisory for executive leadership
• Incident response planning and tabletop exercises
• Vendor security assessments (validating your HIPAA Business Associates)
• Regulatory support for FDA inspections and grant audits
• Security awareness training tailored for research environments

Launch Offer: Free LTFI Security Test for First 10 Massachusetts Biotech Companies

To celebrate our launch, we're offering free comprehensive LTFI security tests to the first 10 Massachusetts biotech, pharmaceutical, or life sciences research organizations that contact us.

This isn't a simple port scan or website check. This is a full LTFI-powered security assessment including:

• Complete attack surface mapping across all digital properties
• Web application vulnerability analysis
• Network security posture assessment
• Detailed remediation guidance prioritized by risk and compliance impact
• Executive briefing on your security posture and compliance gaps

No strings attached. No aggressive sales pitch. Just a genuine offer to help protect Massachusetts research.

Why are we doing this? Because we believe that stronger security across the Massachusetts biotech ecosystem benefits everyone. When research is secure, innovation accelerates. When compliance is streamlined, discoveries reach patients faster.

Our Commitment: Protecting Research That Changes Lives

At MyRHC, we're driven by a singular mission: protect the research that changes lives.

Every day, Massachusetts researchers are:

• Developing gene therapies that could cure previously untreatable diseases
• Running clinical trials that will bring new cancer treatments to patients
• Engineering medical devices that will save lives in emergency rooms
• Conducting basic research that will shape medicine for decades to come

This work is too important to be slowed down by compliance confusion or compromised by security breaches.

We're not here to sell you fear. We're not here to make compliance seem more complicated than it is. We're here to be your trusted partner — the team that understands both the science you're doing and the security you need to protect it.

The Difference Between Compliance and Security

Let's be honest: most compliance programs are theater. Check boxes, generate reports, pass audits, but don't actually improve security.

That's not what we do.

We believe that compliance should be the foundation of actual security, not a substitute for it.

When we implement HIPAA controls, we're not just satisfying audit requirements — we're actually protecting patient data from breaches.

When we design 201 CMR 17.00 programs, we're not just creating written policies — we're implementing technical controls that prevent unauthorized access.

When we validate FDA 21 CFR Part 11 systems, we're not just documenting processes — we're ensuring data integrity that regulators and patients can trust.

Compliance + Real Security = MyRHC Approach

Looking Forward: Building the Future of Massachusetts Biotech Security

This launch is just the beginning. Over the coming months, you'll see MyRHC:

Educational Content

We're committed to publishing weekly educational content:

• Blog posts solving real compliance challenges for Massachusetts biotech
• LinkedIn insights on emerging threats to life sciences research
• Free resources including compliance checklists and security guides
• Webinars and workshops on topics like "HIPAA for Biotech Startups" and "Securing Clinical Trial Data"

Community Engagement

We're becoming active members of the Massachusetts biotech community:

• Speaking at MassBio events and research conferences
• Partnering with biotech incubators and accelerators
• Supporting academic research institutions with educational programs
• Contributing to conversations about improving cybersecurity across the ecosystem

Thought Leadership

We're not just consultants — we're advocates for better approaches to biotech security:

• Publishing research on emerging threats to life sciences organizations
• Advocating for practical compliance frameworks that support innovation
• Sharing lessons learned from our client engagements (anonymized, with permission)
• Pushing the industry forward with innovative security approaches

Join Us: Let's Protect Research Together

Whether you're a biotech startup founder, an academic researcher, a pharmaceutical quality director, or a CRO operations leader — we want to help you protect your research.

Get Your Free LTFI Security Scan

First 10 Massachusetts biotech companies receive a complimentary comprehensive security assessment. No credit card required. No aggressive sales pitch. Just genuine help protecting your research.

Contact us today: [email protected]

Stay Connected

• Website: www.myrhc.com
• LinkedIn: Follow MyRHC for daily insights on biotech compliance and security
• Email Newsletter: Weekly tips on protecting Massachusetts research (sign up at myrhc.com/newsletter)

Let's Talk

Have questions about:

• HIPAA compliance for your clinical trial management system?
• FDA 21 CFR Part 11 requirements for electronic batch records?
• 201 CMR 17.00 written information security programs?
• NIH Guidelines for recombinant DNA research?
• SOC 2 certification for your CRO services?

We're here to help. Book a free 30-minute consultation at myrhc.com/consult.

The Bottom Line: Security Doesn't Have to Slow Down Discovery

For too long, biotech companies have treated security and compliance as obstacles to innovation. Necessary evils that slow down research and consume limited budgets.

We're changing that narrative.

At MyRHC, we believe that properly designed security enables faster, safer innovation. When researchers trust that their data is protected, they collaborate more openly. When executives know their compliance is solid, they make bolder strategic decisions. When patients know their information is secure, they're more willing to participate in clinical trials.

Good security accelerates discovery. That's the MyRHC promise.

Additional Resources for Massachusetts Biotech Companies

Looking to learn more about compliance requirements? Check out these related resources:

• HIPAA Compliance Guide for Massachusetts Biotech Startups (coming soon)
• Understanding Massachusetts 201 CMR 17.00: A Practical Guide (coming soon)
• FDA 21 CFR Part 11 Compliance Checklist for Pharmaceutical Companies (coming soon)
• NIH Guidelines Compliance for Academic Research Labs (coming soon)
• Securing Clinical Trial Data: A Strategic Approach (coming soon)

MyRHC — Massachusetts Regulated, Health & Compliance
Cybersecurity-first consulting for Massachusetts regulated research

Built by Kief Studio | Powered by LTFI